Date: July 18, 2024 By: Nick Kolev
We are delighted to announce the upcoming launch of the Ragon Child Care Center at our new building at 600 Main Street. Operated by Bright Horizons, the Ragon Child Care Center will offer early childhood education and care right at the heart of our community. With programs tailored for infants, toddlers, and preschool-aged children, this center aims to support our employees’ work-life balance by providing a convenient and high-quality child care solution.
Located onsite, the center is scheduled to open this September. It will have the capacity to accommodate 45 children, ensuring that our community members have access to reliable and excellent care for their young ones in the same building where they work. The Ragon Child Care Center’s proximity to the workplace allows for active involvement in children’s early education, making it easier for parents to stay connected and engaged.
Moreover, the Ragon Institute is proud to subsidize the center’s tuition and offer the Susan Ragon Child Care Scholarship to support eligible families. This needs-based scholarship is designed to make quality child care accessible to all members of our community, ensuring that financial barriers do not stand in the way of a child’s education and well-being. This initiative is a testament to our commitment to supporting our employees’ diverse needs and fostering a supportive, inclusive environment.
As an additional effort to continue building ties with the Cambridge community, five spots have also been reserved for Ragon Institute neighbors who are Cambridge Housing Authority residents.
Stay tuned for more updates, and explore Bright Horizons’ resources at brighthorizons.com. We can’t wait to see the positive impact this center will have on our community!
Researchers at the Ragon Institute of Mass General Brigham, MIT, and Harvard have uncovered critical insights into how aging impairs the immune system’s ability to fight cancer.
This study, published in Immunity on August 30, used a non-human primate model to demonstrate that previous Mtb infection leads to a durable, protective immune response that is dependent on CD4+ T cells.
MIT researchers find that the first dose primes the immune system, helping it to generate a strong response to the second dose, a week later.